CN1541678A - Mastoplasia treating medicine - Google Patents
Mastoplasia treating medicine Download PDFInfo
- Publication number
- CN1541678A CN1541678A CNA2003101050495A CN200310105049A CN1541678A CN 1541678 A CN1541678 A CN 1541678A CN A2003101050495 A CNA2003101050495 A CN A2003101050495A CN 200310105049 A CN200310105049 A CN 200310105049A CN 1541678 A CN1541678 A CN 1541678A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- rhizoma
- fructus
- increasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The medicine for treating hyperplasia of mammary glands consists of 19 kinds of Chinese medicinal materials, including bupleurum root, angelica, etc. as basic components, and has other components added to adapt various disease symptoms caused by different causes, such as getting angry, menstruation, climacterium and tumor. The medicine is ultraviolet ray sterilized before grinding.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cyclomastopathy, belong to Chinese medicine.
Background technology
The cyclomastopathy traditional Chinese medical science also claims " nodules of the breast ", is the commonly encountered diseases of female mammary gland disease, is more common in 30-50 year middle-aged women, and its sickness rate accounts for 78% of whole mastopathy, and the probability that should the disease secondary become breast carcinoma than the high 4-6 of general women doubly.For the present domestic most employing RUPIXIAO of the treatment of primary disease, RUHE SANJIE PIAN, poor effect, and recurrence easily.Doctor trained in Western medicine adopts not fragrant sheet treatment of former times of citron acidify mostly, poor effect, and cause side effect such as menoxenia, leucocytes reduction easily, the generation of Breast Cancer Prevention.
Summary of the invention
Purpose of the present invention is exactly to provide a kind of medicine for the treatment of cyclomastopathy for the problem that solves the existence of treatment cyclomastopathy.
Purpose of the present invention reaches by following medicine:
This medicine is made by following materials of weight proportions: Radix Bupleuri 1, Radix Angelicae Sinensis 1, Radix Paeoniae Rubra 1, Cortex Moutan 1, Fructus Aurantii 1, Semen Vaccariae 1, Thallus Laminariae (Thallus Eckloniae) 1, Squama Manis 2/3, Sargassum 1, Rhizoma Chuanxiong 1, Cornu Cervi Pantotrichum 1/3, Rhizoma Cyperi 1, Fructus Forsythiae 1.5, ocean Huo Ye 1, Fructus Toosendan 1, Herba Hedyotidis Diffusae 1, Fructus Trichosanthis 1, Poria 1, Flos Chrysanthemi 1.
Purpose of the present invention can also reach by following medicine:
On original proportioning basis, increase Semen Persicae 1, Flos Carthami 1.
On original proportioning basis, increase Radix Rehmanniae Preparata 1, Herba Cistanches 1.
On original proportioning basis, increase Radix Codonopsis 1.5, Semen Ziziphi Spinosae 1, rhizoma sparganic 1, Rhizoma Curcumae 1.
The method for preparing above-mentioned medicine is each composition to be mixed by proportioning grind into powder after 15 minutes through conventional disinfection by ultraviolet light.
The present invention has following advantage:
1, improves the cure rate of cyclomastopathy, reduce relapse rate, have the effect of regulating the whole body endocrine regulation.
2, instant effect, safely, have no side effect.
3, the medicine source is extensive, and cost is low, taking convenience.
The specific embodiment
Embodiment 1
Prescription 1
Radix Bupleuri 15g, Radix Angelicae Sinensis 15g, Radix Paeoniae Rubra 15g, Cortex Moutan 15g, Fructus Aurantii 15g, Semen Vaccariae 15g, Thallus Laminariae (Thallus Eckloniae) 15g, Squama Manis 10g, Sargassum 15g, Rhizoma Chuanxiong 15g, Cornu Cervi Pantotrichum 5g, Rhizoma Cyperi 15g, Fructus Forsythiae 22.5g, ocean Huo Ye 15g, Fructus Toosendan 15g, Herba Hedyotidis Diffusae 15g, Fructus Trichosanthis 15g, Poria 15g, Flos Chrysanthemi 15g.The uviol lamp sterilization is ground into powder and is formed.
Function: dispersing the stagnated live-QI to relieve the stagnation of QI, dissipating phlegm and resolving masses.Radix Bupleuri, Rhizoma Cyperi, Fructus Aurantii, the circulation of qi promoting of Flos Chrysanthemi soothing liver-QI in the side; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Squama Manis, Semen Vaccariae, blood circulation promoting and dispersing pathogen accumulation, pain relieving; Fructus Trichosanthis reduces phlegm; Thallus Laminariae (Thallus Eckloniae), Sargassum, Fructus Forsythiae, eliminating stagnation; Cornu Cervi Pantotrichum the kidney invigorating, accent dash appoints; The Herba Hedyotidis Diffusae antitumaous effect; Ocean Huo Ye has the male sample effect that swashs.
Indication: have bilateral or one-sided cyclomastopathy increases the weight of when anger.
Instructions of taking: one time 6 gram, a twice-daily, boiled water is taken after mixing it with water, and one month is a course of treatment.
Curative effect: table 1
Group | ????n | Clinical recovery | Effectively | Invalid | Total effective rate | ||||
??n | ??% | ????n | ??% | ????n | ????% | ????n | ????% | ||
The treatment group | ??120 | ??105 | ??87.5 | ????13 | ??10.80 | ????2 | ????1.67 | ????118 | ????98 |
Matched group | ??80 | ??44 | ??55 | ????15 | ??18.75 | ????22 | ????27.50 | ????59 | ????73.75 |
As seen from Table 1, taking prescription 1 cure rate is 87.50%, and matched group is 55.00%, and total effective rate treatment group is 98.00%, and matched group is 73.75%, through check, two groups of total effective rate significant differences, X
2=26.14, P<0.01.
Case (choosing): Guo Hongyan, woman, 32 years old, first visit in February, 1999, primary symptom bilateral breast pain 5 years, increased the weight of in nearly 1 year, bilateral breast is gone up quadrant outward can touch the lamellar enclosed mass, and matter is hard, fidgety irritability, through more so preceding, menoxenia, noctovisor scan, bilateral breast cyclomastopathy.Take prescription 1 treatment two weeks, distending pain of the breast, touching a tender spot obviously alleviates, and symptom did not have in 1 month, continued and obeyed 1 month to consolidate curative effect.
Embodiment 2
Prescription 2
On the basis of prescription 1, increase Semen Persicae 15g, Flos Carthami 15g.
Function: activating QI to eliminate phlegm, eliminating stasis and resolving masses, Semen Persicae, Flos Carthami promoting blood flow to regulate menstruation.
Indication: cyclomastopathy increases the weight of before menstruation
Instructions of taking: the same.
Curative effect: table 2
Group | ??n | Clinical recovery | Effectively | Invalid | Total effective rate | ||||
??n | ??% | ??n | ??% | ??n | ????% | ??n | ????% | ||
The treatment group | ??108 | ??96 | ??88.9 | ??8 | ??7.40 | ??2 | ????1.85 | ??106 | ????98.15 |
Matched group | ??70 | ??35 | ??50 | ??7 | ??10 | ??28 | ????40 | ??42 | ????60 |
As seen from Table 2, prescription 2 cure rates are 88.90%, matched group 50.00%, and total effective rate treatment group is 98.15%, matched group is 60.00%, through check, two groups of total effective rate significant differences, X
2=41.43, P<0.01.
Case (choosing): huge refined China, woman, 24 years old, first visit in March calendar year 2001, both sides distending pain of the breast, two nipples are touched a tender spot and are obviously shown, the big lamellar tuberosity of two outer quadrants, quality is harder, through preceding pain unbearably, the time dysmenorrhea arranged, the photography of bilateral breast molybdenum palladium, bilateral breast glandular hyperplasia, with prescription 2 treatments one month, transference cure serve on 2 months, to consolidate curative effect.
Embodiment 3
Prescription 3
On the basis of prescription 1, increase Radix Rehmanniae Preparata 15g, Herba Cistanches 15g.
Function: enrich blood YIN nourishing, benefit of Chong and Ren Meridians regulating, liver and kidney tonifying, Radix Rehmanniae Preparata is smart, the Herba Cistanches kidney-replenishing.
Indication: the cyclomastopathy during climacteric
Instructions of taking: the same.
Curative effect: table 3
Group | ??n | Clinical recovery | Effectively | Invalid | Total effective rate | ||||
??n | ??% | ????n | ??% | ??n | ??% | ?n | ??% | ||
The treatment group | ??112 | ??99 | ??88.39 | ????11 | ??9.82 | ??2 | ??1.79 | ?110 | ??98.21 |
Matched group | ??100 | ??51 | ??51 | ????10 | ??10 | ??39 | ??39 | ?61 | ??61 |
As seen from Table 3, prescription 3 cure rates are 88.39%, matched group 51.00%, and total effective rate prescription 3 is 98.21%, matched group is 61.00%, through check X
2=44.55, P<0.01.
Case (choosing): Sun Yanjun, woman, 49 years old, first visit in June, 2000, both sides distending pain of the breast, the outer big lamellar tuberosity of bilateral, painful irregular, during two oxter distending pain is arranged, with vexed, the irritability sweating, color ultrasound is shown the bilateral breast hypertrophy, the attached cyclomastopathy of bilateral obviously alleviates with prescription 3 treatment two weeks symptoms, continues and obeys 2 months to consolidate curative effect.
Embodiment 4
Prescription 4
On the basis of prescription 1, increase Radix Codonopsis 22.50g, Semen Ziziphi Spinosae 15g, rhizoma sparganic 15g, Rhizoma Curcumae 15g.
Function: invigorating spleen and nourishing heart, calm the nerves the QI invigorating eliminating stagnation; The Radix Codonopsis spleen reinforcing, Semen Ziziphi Spinosae is calmed the nerves, rhizoma sparganic, Rhizoma Curcumae removing blood stasis repercussive.
Indication: be applicable to for many years cyclomastopathy and the hard person of lump
Instructions of taking: the same.
Curative effect: table 4
Group | ??n | Clinical recovery | Effectively | Invalid | Total effective rate | ||||
??n | ??% | ??n | ??% | ??n | ??% | ??n | ??% | ||
The treatment group | ??120 | ??107 | ??89.17 | ??11 | ??9.17 | ??2 | ??1.67 | ??118 | ??98.33 |
Matched group | ??95 | ??47 | ??49.47 | ??13 | ??13.68 | ??35 | ??36.84 | ??60 | ??63.16 |
As seen from Table 4, the treatment cure rate of prescription 4 is 89.17%, matched group 49.47%, and total effective rate prescription 4 is 98.33%, matched group is 63.16%, through check X
2=43.16, P<0.01.Case (choosing): Wang Jianjun, woman, 32 years old, first visit in March, 1999, bilateral breast show effect surplus the distending pain 10 year repeatedly, and bilateral breast is gone up the big lamellar tuberosity of quadrant outward, the time have vexed, bitter taste, eye to do, with losing the eye dreaminess, unable, the molybdenum palladium shows bilateral breast severe hypertrophy, through prescription 4 treatments one month, the obvious deliquescing of bilateral breast lump, surplus transference cure continues and obeys one month with after treatment.
Claims (5)
1, a kind of medicine for the treatment of cyclomastopathy is characterized in that being made by following materials of weight proportions: Radix Bupleuri 1, Radix Angelicae Sinensis 1, Radix Paeoniae Rubra 1, Cortex Moutan 1, Fructus Aurantii 1, Semen Vaccariae 1, Thallus Laminariae (Thallus Eckloniae) 1, Squama Manis 2/3, Sargassum 1, Rhizoma Chuanxiong 1, Cornu Cervi Pantotrichum 1/3, Rhizoma Cyperi 1, Fructus Forsythiae 1.5, ocean Huo Ye 1, Fructus Toosendan 1, Herba Hedyotidis Diffusae 1, Fructus Trichosanthis 1, Poria 1, Flos Chrysanthemi 1.
2,, it is characterized in that on original proportioning basis, increasing Semen Persicae 1, Flos Carthami 1 according to the said medicine of claim 1.
3,, it is characterized in that on original proportioning basis, increasing Radix Rehmanniae Preparata 1, Herba Cistanches 1 according to the said medicine of claim 1.
4,, it is characterized in that on original proportioning basis, increasing Radix Codonopsis 1.5, Semen Ziziphi Spinosae 1, rhizoma sparganic 1, Rhizoma Curcumae 1 according to the said medicine of claim 1.
5, the method for preparing the said medicine of claim 1 is characterized in that each composition is ground into powder after 15 minutes through conventional disinfection by ultraviolet light by the proportioning mixing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101050495A CN1240419C (en) | 2003-11-07 | 2003-11-07 | Mastoplasia treating medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101050495A CN1240419C (en) | 2003-11-07 | 2003-11-07 | Mastoplasia treating medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1541678A true CN1541678A (en) | 2004-11-03 |
CN1240419C CN1240419C (en) | 2006-02-08 |
Family
ID=34333604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101050495A Expired - Fee Related CN1240419C (en) | 2003-11-07 | 2003-11-07 | Mastoplasia treating medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1240419C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100346802C (en) * | 2004-11-08 | 2007-11-07 | 北京万邦医药投资有限公司 | Chinese medicine composition for preventing and treating hysteromyoma and mammary gland swelling, regulating menstruation and beautifying |
CN101181473B (en) * | 2007-11-15 | 2010-12-22 | 普洱市民族传统医药研究所 | Compound maytenfolic splinter |
CN101401884B (en) * | 2008-11-10 | 2012-05-09 | 贾辉 | Traditional Chinese medicine decoction for treating gland hyperplasia |
CN102908603A (en) * | 2012-10-30 | 2013-02-06 | 王凤 | Chinese medicament for treating hyperplasia of mammary glands |
CN104645165A (en) * | 2015-02-11 | 2015-05-27 | 赵金志 | Traditional Chinese medicine for treating hyperplasia of mammary glands |
CN104840804A (en) * | 2015-06-15 | 2015-08-19 | 王艳娣 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
CN105031545A (en) * | 2015-08-28 | 2015-11-11 | 咸阳夏华中医乳腺病研究所 | Orally taken traditional Chinese medicine for treating hyperplasia of mammary glands |
-
2003
- 2003-11-07 CN CNB2003101050495A patent/CN1240419C/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100346802C (en) * | 2004-11-08 | 2007-11-07 | 北京万邦医药投资有限公司 | Chinese medicine composition for preventing and treating hysteromyoma and mammary gland swelling, regulating menstruation and beautifying |
CN101181473B (en) * | 2007-11-15 | 2010-12-22 | 普洱市民族传统医药研究所 | Compound maytenfolic splinter |
CN101401884B (en) * | 2008-11-10 | 2012-05-09 | 贾辉 | Traditional Chinese medicine decoction for treating gland hyperplasia |
CN102908603A (en) * | 2012-10-30 | 2013-02-06 | 王凤 | Chinese medicament for treating hyperplasia of mammary glands |
CN102908603B (en) * | 2012-10-30 | 2014-06-18 | 王凤 | Chinese medicament for treating hyperplasia of mammary glands |
CN104645165A (en) * | 2015-02-11 | 2015-05-27 | 赵金志 | Traditional Chinese medicine for treating hyperplasia of mammary glands |
CN104840804A (en) * | 2015-06-15 | 2015-08-19 | 王艳娣 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands |
CN105031545A (en) * | 2015-08-28 | 2015-11-11 | 咸阳夏华中医乳腺病研究所 | Orally taken traditional Chinese medicine for treating hyperplasia of mammary glands |
CN105031545B (en) * | 2015-08-28 | 2018-09-11 | 咸阳夏华中医乳腺病研究所 | A kind of traditional Chinese medicine for oral administration for treating the proliferation of mammary gland |
Also Published As
Publication number | Publication date |
---|---|
CN1240419C (en) | 2006-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1053366C (en) | Chinese herbal medicine composition | |
CN1060664C (en) | Chinese drug for curing and preventing mastosis and its preparing method | |
CN1943683A (en) | An external use medicinel and beauty composition for treatment of and preventing chloasma | |
CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
CN1150009C (en) | Medicine for female acyesis | |
CN1289121C (en) | Medicine for promoting ovulation and aiding pregnancy | |
CN1931301A (en) | Chinese medicine prepn for treating mastoproliferation and its prepn process | |
CN1240419C (en) | Mastoplasia treating medicine | |
CN1183919C (en) | Cancer treating medical composition | |
CN101229302A (en) | Chinese traditional medicine for treating mammary glands hyperplasia | |
CN1966067A (en) | Medicament for treating aplastic anemia | |
CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
CN1709288A (en) | Medicinal composition, and its preparing method and use | |
CN1188153C (en) | Medicines for treating cancers and tumours | |
CN102100779A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands by soothing liver and relieving depression | |
CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
CN1285354C (en) | Medicine for treating cerebral infarction | |
CN1169555C (en) | Decocted pill medicine for treating excess syndrome of hepatitis B | |
CN1112208C (en) | Chinese medicine for treating intraocular hemorrhage | |
CN1352978A (en) | Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process | |
CN103893621A (en) | Traditional Chinese medicament for treating senile vaginitis | |
CN1377672A (en) | Rheumatic pain killing preparation | |
CN1059800C (en) | Injection containing ginseng and astragalus root components | |
CN103191369A (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
CN1883636A (en) | Medicine for treating mammary gland hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060208 Termination date: 20151107 |
|
EXPY | Termination of patent right or utility model |